Clinical trial · Observational
Tissue Repository for Studies of Myasthenia Gravis
NCT02902536CI-TRIAL-00040595completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a study during which the investigators collect plasma and cells from patients with myasthenia gravis for the purpose of finding new antibodies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myasthenia Gravis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No interventions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Myasthenia Positive Antibodies
- description
- Patients with Acetyl choline receptor (AChR) or muscle-specific kinase (MuSK) Positive Myasthenia
- interventionNames
- Other: No interventions
- label
- Myasthenia Double Negative
- description
- Patients without AChR or MuSK antibodies
- interventionNames
- Other: No interventions
- label
- Normal Controls
- description
- Patients without myasthenia
- interventionNames
- Other: No interventions
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years of age or older. * Clinical Diagnosis of MG with supporting evidence either from antibody testing, repetitive nerve stimulations study (RNS) or Single Fiber Electromyography (EMG) (SFEMG). Exclusion Criteria: * Significant medical condition that would make participation in diagnostic and research part of evaluation impossible or risky. Acute or unstable medical condition. * Inability to provide informed consent, either directly or via appointed power of attorney. * Unwillingness to consent for collection of biological samples or their cryopreservation. * Unable to provide evidence of previous antibody testing or neurophysiology confirming the diagnosis of Myasthenia Gravis. * Any bleeding disorder that would prevent or present any danger during blood extraction.
References
Publications (0)
Data not yet available
No reference posted for this study.